This article was originally published in The Rose Sheet
Executive SummaryFrench firm unveils invitroskin.com, a Web site exploring the applications of reconstructed skin in basic research and its role in the development of animal testing alternatives, according to the company. Web site addresses skin engineering and answers questions regarding the development of reconstructed skin and how models can serve as alternatives to animal testing. L'Oréal is committed to the field of reconstituted skin, the firm said, citing the company's organization of the 3rd International Skin Engineering Symposium in Lausanne, Switzerland in October 2004. L'Oréal created skin-science.com in 2002, offering information on reconstructed skin and advice for maintaining healthy skin...
You may also be interested in...
Phase III data earns a breakthrough therapy designation for Resverlogix’ apabetalone; previous companies to follow that strategy swiftly advance to NDA submission, as seen with Novartis’ capmatinib and Seattle Genetics’ tucatinib.
Pink Sheet analysis finds that evidence from early-stage trials supports most BTD requests, but about three in 10 designations are granted on the basis of pivotal-stage data.
Four House hearings show how far away even many Democrats are from supporting a single payer system in the US.